Colfosceril palmitate
Pharmaceutical drug
- R07AA01 (WHO)
- 2,3-di(hexadecanoyloxy)propyl 2-trimethylazaniumylethyl phosphate
- 63-89-8 Y
- 6138
- 5908 Y
- 319X2NFW0A
- D03585 Y
- ChEMBL1200737 N
- DTXSID5046720
- Interactive image
- O=C(OCC(OC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCCCCCCCCC
InChI
- InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3 Y
- Key:KILNVBDSWZSGLL-UHFFFAOYSA-N Y
Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.[1] It is a drug that is used in surfactant deficient conditions such as infant respiratory distress syndrome in newborns.
See also
- Dipalmitoylphosphatidylcholine
References
- ^ Rubin BK (1996). "Therapeutic aerosols and airway secretions". Journal of Aerosol Medicine. 9 (1): 123–30. doi:10.1089/jam.1996.9.123. PMID 10160202.
- v
- t
- e
Other respiratory system products (R07)
- Colfosceril palmitate
- Dipalmitoylphosphatidylcholine
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e